Donald Pinto

4.7k total citations · 1 hit paper
58 papers, 3.5k citations indexed

About

Donald Pinto is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Donald Pinto has authored 58 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 24 papers in Hematology and 13 papers in Internal Medicine. Recurrent topics in Donald Pinto's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Donald Pinto is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Donald Pinto collaborates with scholars based in United States, Germany and Kenya. Donald Pinto's co-authors include Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler, Joseph M. Luettgen, Donglu Zhang, Patrick Y. S. Lam, David Negus, Nicholas Brown, Michael H. Chapman and L P Le Quesne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

Donald Pinto

58 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

2008 490 citations Nirmala Raghavan, Charles Frost et al. Drug Metabolism and Disposition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald Pinto United States	28	1.6k	1.1k	720	672	513	58	3.5k
Robert M. Knabb United States	36	1.9k 1.2×	1.0k 0.9×	1.0k 1.4×	1.3k 1.9×	751 1.5×	98	4.3k
Wolfgang Wienen Germany	28	2.3k 1.4×	1.1k 1.0×	408 0.6×	440 0.7×	1.1k 2.2×	48	4.2k
Elisabeth Perzborn Germany	30	2.8k 1.8×	2.0k 1.8×	216 0.3×	841 1.3×	614 1.2×	70	4.4k
Pierre Savi France	40	2.9k 1.8×	911 0.8×	452 0.6×	1.2k 1.8×	1.3k 2.5×	90	6.1k
Joseph M. Luettgen United States	27	999 0.6×	491 0.4×	736 1.0×	838 1.2×	460 0.9×	72	2.5k
Ulf G. Eriksson Sweden	30	1.4k 0.9×	1.2k 1.0×	150 0.2×	523 0.8×	447 0.9×	103	3.2k
Alexander Straub Germany	21	833 0.5×	338 0.3×	637 0.9×	257 0.4×	891 1.7×	41	2.5k
Norbert Hauel Germany	16	909 0.6×	452 0.4×	430 0.6×	290 0.4×	551 1.1×	31	2.1k
Ruth R. Wexler United States	43	4.5k 2.9×	523 0.5×	2.0k 2.7×	1.1k 1.7×	3.5k 6.9×	180	8.9k
Sven Nylander Sweden	26	1.4k 0.9×	569 0.5×	112 0.2×	415 0.6×	431 0.8×	52	2.6k

Countries citing papers authored by Donald Pinto

Since Specialization

Citations

This map shows the geographic impact of Donald Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Pinto more than expected).

Fields of papers citing papers by Donald Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Pinto. The network helps show where Donald Pinto may publish in the future.

Co-authorship network of co-authors of Donald Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Pinto. A scholar is included among the top collaborators of Donald Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Pinto. Donald Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corte, James R., Tianan Fang, Donald Pinto, et al.. (2017). Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker. Journal of Medicinal Chemistry. 60(3). 1060–1075. 29 indexed citations

Corte, James R., Tianan Fang, Donald Pinto, et al.. (2016). Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. Bioorganic & Medicinal Chemistry. 24(10). 2257–2272. 15 indexed citations

Pinto, Donald, Joanne M. Smallheer, James R. Corte, et al.. (2015). Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties. Bioorganic & Medicinal Chemistry Letters. 25(7). 1635–1642. 26 indexed citations

Orwat, Michael J., Jennifer X. Qiao, Kan He, et al.. (2014). Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties. Bioorganic & Medicinal Chemistry Letters. 24(15). 3341–3345. 7 indexed citations

He, Kan, Joseph M. Luettgen, Donglu Zhang, et al.. (2011). Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor. European Journal of Drug Metabolism and Pharmacokinetics. 36(3). 129–139. 71 indexed citations

Wong, Pancras C., Donald Pinto, & Donglu Zhang. (2011). Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor. Journal of Thrombosis and Thrombolysis. 31(4). 478–492. 140 indexed citations

Quan, Mimi L., Donald Pinto, Karen A. Rossi, et al.. (2010). Phenyltriazolinones as potent factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(4). 1373–1377. 10 indexed citations

Wang, Lifei, Nirmala Raghavan, Kan He, et al.. (2009). Sulfation of O-Demethyl Apixaban: Enzyme Identification and Species Comparison. Drug Metabolism and Disposition. 37(4). 802–808. 48 indexed citations

Raghavan, Nirmala, Charles Frost, Zhigang Yu, et al.. (2008). Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans. Drug Metabolism and Disposition. 37(1). 74–81. 490 indexed citations breakdown →

10.

Corte, James R., Tianan Fang, Donald Pinto, et al.. (2008). Structure–activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties. Bioorganic & Medicinal Chemistry Letters. 18(9). 2845–2849. 27 indexed citations

11.

Varnes, Jeffrey, Dean A. Wacker, Donald Pinto, et al.. (2007). Structure–activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 749–754. 29 indexed citations

12.

Qiao, Jennifer X., Xuhong Cheng, Joanne M. Smallheer, et al.. (2006). Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues. Bioorganic & Medicinal Chemistry Letters. 17(5). 1432–1437. 18 indexed citations

13.

Pinto, Donald, Robert A. Galemmo, Mimi L. Quan, et al.. (2006). Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties. Bioorganic & Medicinal Chemistry Letters. 16(21). 5584–5589. 23 indexed citations

14.

Wong, Pancras C., Donald Pinto, & Robert M. Knabb. (2002). Nonpeptide Factor Xa Inhibitors: DPC423, a Highly Potent and Orally Bioavailable Pyrazole Antithrombotic Agent. Cardiovascular Drug Reviews. 20(2). 137–152. 37 indexed citations

15.

Pieniaszek, Henry J., Harry L. Walton, Donald Pinto, et al.. (2002). A double antibody radioimmunoassay for the determination of XV459, the active hydrolysis metabolite of roxifiban, in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 30(5). 1441–1449. 7 indexed citations

16.

Fevig, John M., Donald Pinto, Qi Han, et al.. (2001). Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core. Bioorganic & Medicinal Chemistry Letters. 11(5). 641–645. 31 indexed citations

17.

Pruitt, James R., Donald Pinto, Lori L. Bostrom, et al.. (2000). Isoxazolines and isoxazoles as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(8). 685–689. 59 indexed citations

18.

Pinto, Donald, Douglas G. Batt, William J. Pitts, et al.. (1999). Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the central ring and o-biphenyl analogs. Bioorganic & Medicinal Chemistry Letters. 9(7). 919–924. 17 indexed citations

19.

Pitts, William J., James W. Jetter, Donald Pinto, et al.. (1998). Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent brequinar sodium. Bioorganic & Medicinal Chemistry Letters. 8(3). 307–312. 15 indexed citations

20.

Wright, Stephen W., Richard R. Harris, Janet S. Kerr, et al.. (1992). Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis. Journal of Medicinal Chemistry. 35(22). 4061–4068. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact